 SEATTLE, Feb. 03, 2021 GLOBE NEWSWIRE -- Sana Biotechnology, Inc. Sana Nasdaq: SANA, a company focused on creating and delivering engineered cells as medicines, today announced the pricing of its upsized initial public offering of 23,500,000 shares of its common stock at a public offering price of 25.00 per share. All of the shares of common stock are being offered by Sana. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sana, are expected to be 587.5 million. Sanas common stock is expected to begin trading on The Nasdaq Global Select Market on February 4, 2021, under the ticker symbol SANA. The offering is expected to close on February 8, 2021, subject to the satisfaction of customary closing conditions. In addition, Sana has granted the underwriters a 30-day option to purchase up to an additional 3,525,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions, and, if exercised in full, would result in aggregate gross proceeds of approximately 675.6 million. 